SBIR Phase I: Long Lasting Organic Formulation to Effectively Manage Blood Sucking Diptera

点击翻译按钮获取中文摘要

This Small Business Innovation Research (SBIR) Phase Iproject will develop a long lasting organic formulation to effectively manage andsuppress populations of mosquito vectors of disease. The banning of DDT andother persistent mosquito larvicides several decades ago has created a major gapin vector management that has yet to be effectively filled by generations ofenvironmentally friendly chemicals and formulations that followed. Theconsequences are tangible to the human population worldwide. We are currentlyexperiencing more pain, suffering, and deaths from mosquito transmitteddiseases than when DDT was available. Biological larvicidal formulations havebeen proven safe and effective in controlling mosquito larvae, with the caveatthat they have a very short field life which requires frequent reapplications tosustain control, in turn making them too expensive for adoption by most areawidevector control programs. Because of this, biological larvicidal formulationsare seldom used preventatively. This SBIR project will bridge this gap andincrease the longevity, and usability, of biological larvicides. Success will result indirect mitigation of soil and waterways pollution commonly associated withconventional pesticides for mosquito control.The broader/commercial impacts of this research are, ifthis SBIR project is successful, the development of a biological, long lastinglarvicidal formulation that will significantly change the way parasitic mosquitoesare managed worldwide, making it much more effective, reducing disease andsuffering, and saving lives while significantly reducing non-target effects andenvironmental pollution. This is a worldwide market opportunity of over$2B/year.